Literature DB >> 27643898

Stroke: New Developments and Their Application in Clinical Practice.

Peter J Kelly1, Eoin Kavanagh2, Sean Murphy3.   

Abstract

Significant advances have been made in recent years in primary stroke prevention, improved stroke outcomes in high-income populations, emergency stroke therapy, and stroke prevention. In this article, we review recent trends in stroke epidemiology, improvements in delivery of intravenous thrombolysis (via stroke system-wide approaches, application of 'Lean Principles' to improve workflow processes, and re-evaluation of exclusion criteria), recent stroke thrombectomy trials, and new developments in stroke prevention, with emphasis on risk prediction in transient ischemic attack, choice and timing of anticoagulation therapy for secondary stroke prevention, and emerging concepts in risk stratification for management of symptomatic carotid stenosis. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27643898     DOI: 10.1055/s-0036-1586261

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  3 in total

Review 1.  Recent advances in the development of nanomedicines for the treatment of ischemic stroke.

Authors:  Xing Tian; Taojian Fan; Wentian Zhao; Ghulam Abbas; Bo Han; Ke Zhang; Nan Li; Ning Liu; Weiyuan Liang; Hao Huang; Wen Chen; Bing Wang; Zhongjian Xie
Journal:  Bioact Mater       Date:  2021-02-20

2.  Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia.

Authors:  Tian Tian; Lei Cao; Chuan He; Qing Ye; Ruyu Liang; Weiyan You; Huixin Zhang; Jiahuan Wu; Jinhai Ye; Bakhos A Tannous; Jun Gao
Journal:  Theranostics       Date:  2021-04-19       Impact factor: 11.556

3.  A novel brain targeted plasma exosomes enhance the neuroprotective efficacy of edaravone in ischemic stroke.

Authors:  Lin Guo; Junlu Pan; Fang Li; Liang Zhao; Yijie Shi
Journal:  IET Nanobiotechnol       Date:  2021-02-02       Impact factor: 2.050

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.